ArticleImmunotherapy2025

Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors.

Taha Koray Sahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.